Literature DB >> 25636509

Crk-like adapter protein regulates CCL19/CCR7-mediated epithelial-to-mesenchymal transition via ERK signaling pathway in epithelial ovarian carcinomas.

Shaomei Cheng1, Jingyan Guo, Qing Yang, Xiangshan Yang.   

Abstract

Recent studies have suggested that Crk-like adapter protein (CrkL) and epithelial-to-mesenchymal transition (EMT) induced by CCL19/CCR7 play an important role in ovarian epithelial carcinogenesis. However, the regulatory mechanisms of CrkL on the CCL19/CCR7 signaling pathways in epithelial ovarian carcinomas (EOC) are not well characterized. Here, CCR7 and CrkL proteins were tested in 30 EOC tissues and cell lines. In vitro, the roles of CrkL in CCL19-stimulated SKOV-3 cell invasion and migration were investigated. In this work, CCR7 and CrkL over-expressed in EOC tissues and cell lines and correlated with FIGO stage and lymph node metastasis. Moreover, CCR7 and CrkL serve as an independent prognostic factor. In SKOV-3 cells, CrkL knockdown markedly suppressed the CCL19-stimulated expression of p-ERK and EMT biomarkers (N-cadherin, Snail and MMP9), compared with control. In contrast, p-AKT expression level did not change. On the other hand, functional analysis revealed CrkL knockdown could significantly decrease SKOV-3 cell invasion number of transwell invasion assay, and wound closure area of wound healing assay, compared to control. In conclusion, CrkL regulates CCL19/CCR7-induced EMT via ERK signaling pathway in EOC patients, which further suggested CrkL could be suggested as an efficient target in ovarian cancer treatment.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25636509     DOI: 10.1007/s12032-015-0494-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  25 in total

Review 1.  Epithelial-mesenchymal transitions in development and disease.

Authors:  Jean Paul Thiery; Hervé Acloque; Ruby Y J Huang; M Angela Nieto
Journal:  Cell       Date:  2009-11-25       Impact factor: 41.582

2.  Ovarian cancer development and metastasis.

Authors:  Ernst Lengyel
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 3.  Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma.

Authors:  Wolfgang Wick; Ulrike Naumann; Michael Weller
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Hypoxia stimulates hepatocyte epithelial to mesenchymal transition by hypoxia-inducible factor and transforming growth factor-beta-dependent mechanisms.

Authors:  Bryan L Copple
Journal:  Liver Int       Date:  2010-02-15       Impact factor: 5.828

Review 5.  The epithelial-mesenchymal transition (EMT) phenomenon.

Authors:  P Savagner
Journal:  Ann Oncol       Date:  2010-10       Impact factor: 32.976

Review 6.  Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis.

Authors:  Ie-Ming Shih; Robert J Kurman
Journal:  Am J Pathol       Date:  2004-05       Impact factor: 4.307

7.  Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition.

Authors:  Debra F Higgins; Kuniko Kimura; Wanja M Bernhardt; Nikita Shrimanker; Yasuhiro Akai; Bernd Hohenstein; Yoshihiko Saito; Randall S Johnson; Matthias Kretzler; Clemens D Cohen; Kai-Uwe Eckardt; Masayuki Iwano; Volker H Haase
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

8.  Integrative analysis of high-throughput RNAi screen data identifies the FER and CRKL tyrosine kinases as new regulators of the mitogenic ERK-dependent pathways in transformed cells.

Authors:  Philippe Nizard; Frédéric Ezan; Dominique Bonnier; Nolwenn Le Meur; Sophie Langouët; Georges Baffet; Yannick Arlot-Bonnemains; Nathalie Théret
Journal:  BMC Genomics       Date:  2014-12-23       Impact factor: 3.969

9.  Crk and CrkL adaptor proteins: networks for physiological and pathological signaling.

Authors:  Raymond B Birge; Charalampos Kalodimos; Fuyuhiko Inagaki; Shinya Tanaka
Journal:  Cell Commun Signal       Date:  2009-05-10       Impact factor: 5.712

10.  The essential roles of CCR7 in epithelial-to-mesenchymal transition induced by hypoxia in epithelial ovarian carcinomas.

Authors:  Shaomei Cheng; Lin Han; Jingyan Guo; Qing Yang; Jianfang Zhou; Xiangshan Yang
Journal:  Tumour Biol       Date:  2014-08-29
View more
  23 in total

1.  Silencing of CCR7 inhibits the growth, invasion and migration of prostate cancer cells induced by VEGFC.

Authors:  Bao-Jin Chi; Cong-Lin Du; Yun-Feng Fu; Ya-Nan Zhang; Ru Wen Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

2.  Fibroblast Growth Requires CT10 Regulator of Kinase (Crk) and Crk-like (CrkL).

Authors:  Taeju Park; Mateusz Koptyra; Tom Curran
Journal:  J Biol Chem       Date:  2016-11-02       Impact factor: 5.157

Review 3.  Does CCL19 act as a double-edged sword in cancer development?

Authors:  Arezoo Gowhari Shabgah; Zaid Mahdi Jaber Al-Obaidi; Heshu Sulaiman Rahman; Walid Kamal Abdelbasset; Wanich Suksatan; Dmitry O Bokov; Lakshmi Thangavelu; Abduladheem Turki Jalil; Farhad Jadidi-Niaragh; Hamed Mohammadi; Kazem Mashayekhi; Jamshid Gholizadeh Navashenaq
Journal:  Clin Exp Immunol       Date:  2022-04-04       Impact factor: 4.330

Review 4.  C-C Chemokine Receptor 7 in Cancer.

Authors:  Colin A Bill; Christopher M Allen; Charlotte M Vines
Journal:  Cells       Date:  2022-02-14       Impact factor: 6.600

5.  Expression of chemokine receptor CXCR4 is closely correlated with clinical outcome in human nasopharyngeal carcinoma.

Authors:  Hengmin Tao; Yumei Wei; Congan Wang; Kun Yang; Wei Huang; Haitao Liu; Baosheng Li
Journal:  Tumour Biol       Date:  2015-11-26

Review 6.  Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.

Authors:  Aliyah M Weinstein; Walter J Storkus
Journal:  Adv Cancer Res       Date:  2015-05-05       Impact factor: 6.242

7.  CCR7 regulates ANO6 to promote migration of pancreatic ductal adenocarcinoma cells via the ERK signaling pathway.

Authors:  Long Wang; Xiang-Yun Zhao; Jin-Shui Zhu; Ni-Wei Chen; Hui-Ning Fan; Wei Yang; Jing-Hui Guo
Journal:  Oncol Lett       Date:  2018-06-13       Impact factor: 2.967

8.  Methylomic Signatures of High Grade Serous Ovarian Cancer.

Authors:  Horacio Cardenas; Fang Fang; Guanglong Jiang; Susan M Perkins; Chi Zhang; Robert E Emerson; George Hutchins; Harold N Keer; Yunlong Liu; Daniela Matei; Kenneth Nephew
Journal:  Epigenetics       Date:  2020-12-08       Impact factor: 4.528

9.  CRKL oncogene is downregulated by p53 through miR-200s.

Authors:  Miyuki Tamura; Yasushi Sasaki; Kenta Kobashi; Kousuke Takeda; Takafumi Nakagaki; Masashi Idogawa; Takashi Tokino
Journal:  Cancer Sci       Date:  2015-07-14       Impact factor: 6.716

10.  SLC7A5 Functions as a Downstream Target Modulated by CRKL in Metastasis Process of Gastric Cancer SGC-7901 Cells.

Authors:  Junqing Wang; Xiaochun Fei; Weize Wu; Xuehua Chen; Liping Su; Zhenggang Zhu; Yunyun Zhou
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.